Adjuvant Treatment of Triple-Negative Metaplastic Breast Cancer With Weekly Paclitaxel and Platinum Chemotherapy: Retrospective Case Review From a Single Institution

被引：6
|
作者：
Harper, Natalie W. [1 ]
Hodges, Kurt B. [2 ]
Stewart, Rachel L. [2 ,5 ]
Wu, Jianrong [3 ,5 ]
Huang, Bin [3 ,5 ]
O'Connor, Kathleen L. [4 ,5 ]
Romond, Edward H. [1 ,5 ]
机构：
[1] Univ Kentucky, Dept Internal Med, Div Med Oncol, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40536 USA
[3] Univ Kentucky, Biostat & Bioinformat Shared Resource Facil, Markey Canc Ctr, Lexington, KY 40536 USA
[4] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA
[5] Univ Kentucky, Markey Canc Ctr, 203 Combs Bldg, Lexington, KY 40536 USA
来源：
CLINICAL BREAST CANCER | 2019年 / 19卷 / 04期
基金：
美国国家卫生研究院;
关键词：
Carboplatin; Taxane; TUMOR-INITIATING CELLS; MESENCHYMAL TRANSITION; SARCOMATOID CARCINOMA; CARBOPLATIN; OUTCOMES; MARKERS; TRIAL;
D O I：
10.1016/j.clbc.2019.05.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E495 / E500
页数：6
相关论文
共 50 条
  • [41] Adjuvant chemotherapy in small node-negative triple-negative breast cancer (TNBC).
    Steenbruggen, Tessa Gerjanne
    Van Ramshorst, Mette S.
    van Werkhoven, Erik
    Dezentje, Vincent O.
    Siesling, Sabine
    Linn, Sabine C.
    Sonke, Gabe S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] A retrospective review of demographics and stage of triple-negative breast cancer
    Rana, F. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Combining Chemotherapy and Immunotherapy for the Treatment of Triple-Negative Breast Cancer
    McArthur, Heather
    ONCOLOGY-NEW YORK, 2019, 33 (04): : 137 - 140
  • [44] CHARACTERISTICS AND PROGNOSIS OF TRIPLE-NEGATIVE BREAST CANCER PATIENTS: A CROATIAN SINGLE INSTITUTION RETROSPECTIVE COHORT STUDY
    Vuger, Ana Tecic
    Separovic, Robert
    Vazdar, Ljubica
    Pavlovic, Mirjana
    Lepetic, Petra
    Sitic, Sanda
    Bajic, Zarko
    Sarcevic, Bozena
    Vrbanec, Damir
    ACTA CLINICA CROATICA, 2020, 59 (01) : 97 - 108
  • [45] (Neo)Adjuvant Carboplatin-Based Chemotherapy in the Treatment of Triple Negative Early Breast Cancer - Experience at a single UK Institution
    Armstrong, A.
    Coe, F.
    Frank, S.
    Howell, S.
    Wright, P.
    Mccabe, Y.
    Morris, D.
    Wardley, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S106 - S106
  • [46] Most neoadjuvant chemotherapy for triple-negative breast cancer should include platinum
    Dent, Rebecca
    LANCET ONCOLOGY, 2021, 22 (01): : 27 - 28
  • [47] A brief review of treatment options for neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Tiwari, Akash
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (02) : 247 - 249
  • [48] Erratum to: Platinum-based chemotherapy in triple-negative advanced breast cancer
    Cynthia Villarreal-Garza
    Daniel Khalaf
    Nathaniel Bouganim
    Mark Clemons
    Omar Peña-Curiel
    Berenice Baez-Revueltas
    Alexander Kiss
    Farah Kassam
    Katherine Enright
    Sunil Verma
    Kathleen Pritchard
    Jeff Myers
    Rebecca Dent
    Breast Cancer Research and Treatment, 2015, 150 : 697 - 697
  • [49] Metaplastic Breast Carcinoma: Evaluation of Triple-negative Metaplastic Breast Cancer and Non-triple-negative Metaplastic Breast Cancer in Terms of Clinico-pathologic Features, Treatment Modalities, and Clinical Outcomes
    Sajjad, Barka
    Daula, Awais Kanwal
    Saeed, Adnan
    Farooqi, Nifasat
    Khalid, Umaisa
    Amir, Momina
    Tariq, Tahla
    Zubair, Umrah
    Khan, Amina
    Choudary, Muhammad Zulqarnain
    Rehman, Bushra
    Parvaiz, Muhammad
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S548 - S549
  • [50] Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review
    Trapani, D.
    Giugliano, F.
    Uliano, J.
    Zia, V. A. A.
    Marra, A.
    Viale, G.
    Ferraro, E.
    Esposito, A.
    Criscitiello, C.
    D'amico, P.
    Curigliano, G.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 323 - 337
12345